Investigating hearing loss in Black and White adults with high blood pressure
Assessment of Cochlear Dysfunction in Black and White Adults with Stage 2 Hypertension Using High-Frequency Distortion Product Otoacoustic Emissions
This study is looking at how high blood pressure, especially Stage 2 hypertension, might impact hearing in Black and White adults, and it aims to find early signs of hearing issues so we can improve detection and treatment for hearing loss.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado NIH-funded |
| Lab location | 1 site (Boulder, UNITED STATES) |
| Project ID | NIH-11063120 on NIH RePORTER |
What this research studies
This research aims to explore how high blood pressure, specifically Stage 2 hypertension, affects hearing function in Black and White adults. By using advanced techniques to measure cochlear function, the study seeks to identify early signs of hearing damage that may be linked to hypertension. The goal is to understand any differences in auditory health between these two populations, which could lead to better early detection and intervention strategies for hearing loss. Participants will undergo assessments that measure the health of the cochlea, which is crucial for hearing.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black and White adults aged 21 and older who have been diagnosed with Stage 2 hypertension.
Not a fit: Patients without hypertension or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection and treatment strategies for hearing loss in individuals with high blood pressure.
How similar studies have performed: Previous research has indicated a link between hypertension and hearing loss, suggesting that this study builds on established findings rather than exploring a completely novel area.
Where this research is happening
Boulder, UNITED STATES
- University of Colorado — Boulder, United States (Active)
Researchers
- Principal investigator: Baiduc, Rachael Rebecca — University of Colorado
- Study coordinator: Baiduc, Rachael Rebecca
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.